Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,051 public trials 1,181 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients

NCT00699816

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Korea University Ansan Hospital Ansan-si, Gojan1-dong/Danwon-gu, South Korea
  • Korea University Guro Hospital Seoul, Guro 2-Dong, Guro-Gu, South Korea
  • Samsung Medical Center Seoul, Ilwon-dong/Gangnam-gu, South Korea
  • Seoul Asan Medical center Seoul, Pungnab2-dong/Songpa-gu, South Korea
View Trial Details
Completed

Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer

NCT01107626

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +14 more
Locations
  • Regional Medical Center Anniston, Alabama, United States
  • Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • North Bay Cancer Center Fairfield, California, United States
  • Todd Cancer Institute at Long Beach Memorial Medical Center Long Beach, California, United States
View all 434 locations
View Trial Details
Completed

Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma

NCT00068393

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • University of Colorado Cancer Center at UC Health Sciences Center Aurora, Colorado, United States
  • Rush-Copley Cancer Care Center Aurora, Illinois, United States
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
View all 92 locations
View Trial Details
Completed

BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

NCT00828009

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Medical Center of Central Georgia Macon, Georgia, United States
  • St. Joseph Medical Center Bloomington, Illinois, United States
View all 88 locations
View Trial Details
Completed

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

NCT00427349

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +25 more
Locations
  • Hematology Oncology Associates of Illinois - Berwyn Berwyn, Illinois, United States
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
  • Hematology and Oncology Associates Chicago, Illinois, United States
  • Midwest Center for Hematology/Oncology Joliet, Illinois, United States
View all 112 locations
View Trial Details
Completed

Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver

NCT00003907

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations
  • Front Range Cancer Specialists Fort Collins, Colorado, United States
  • Baptist Cancer Institute - Jacksonville Jacksonville, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Veterans Affairs Medical Center - Atlanta (Decatur) Decatur, Georgia, United States
View all 37 locations
View Trial Details
Completed

Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer

NCT02267603

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +18 more
Locations
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • Yale University New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 13 locations
View Trial Details
Completed

TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers

NCT03829436

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • University of California - San Francisco San Francisco, California, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details

Related conditions